Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

We present a case of unilateral, secondary open-angle glaucoma due to an underlying diffuse iris melanoma. The patient was referred by his ophthalmologist with uncontrolled, elevated intraocular ...

Among patients with suspected or confirmed glaucoma, higher average blood pressure and greater variability in blood pressure ...

Both glaucoma and cancer of the eye may lead to temporary or permanent vision loss, among other vision-related challenges. Early stages of open-angle glaucoma may not cause evident symptoms.

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

New study challenges conventional wisdom about cholesterol! High levels of 'good cholesterol' may increase the risk of ...

More than 4.2 million Americans live with glaucoma, a leading cause of vision loss in the nation. Although there is no cure ...

Glaucoma is one of the leading causes of blindness for people over the age of 60 but early detection and treatment can help ...

Touting its novel approach for treating glaucoma, Qlaris Bio Inc. reported promising top-line data from two phase II studies testing QLS-111 in patients with primary open-angle glaucoma and ocular ...

Goniotomy was found to be a safe conjunctival-sparing approach that effectively reduced intraocular pressure over the long term in children with glaucoma secondary to uveitis.

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

That’s why Optegra Eye Hospital Bradford is supporting ... estimated that around 2% of people over the age of 40 have open angle glaucoma, the most common form. The prevalence increases with ...